| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 10/04/2006 | EP1706095A1 Compositions for localized therapy of the eye, comprising preferably triamcinolone acetonide and hyaluronic acid |
| 10/04/2006 | EP1668358A4 Reconstitution medium for protein and peptide formulations |
| 10/04/2006 | EP1558227B1 Injectable 2,6-diisopropylphenol-containing anesthetic composition and methods |
| 10/04/2006 | EP1545206A4 Compositions and products containing enantiomeric equol, and methods for their making |
| 10/04/2006 | EP1482936B1 Ophthalmic composition comprising ascomycin |
| 10/04/2006 | EP1467622A4 Mitocidal compositions and methods |
| 10/04/2006 | EP1423392B1 Derivatives of morphine-like opioid compounds |
| 10/04/2006 | EP1368019B1 Esmolol formulation |
| 10/04/2006 | EP1349541B1 Self emulsifying lipid matrix (selm) |
| 10/04/2006 | EP1341515B1 Water-free skin care formulations comprising micronized urea and method of manufacturing the same |
| 10/04/2006 | EP1280840B1 Polyurethane and the use thereof for modifying rheological properties |
| 10/04/2006 | EP1259225B1 Process of dehydration/rehydration for making liposomes |
| 10/04/2006 | EP1185309B1 Liquid gel composition for mapping a breast milk duct prior to surgical excision of the duct or other breast tissue |
| 10/04/2006 | EP1174137B1 Patches containing buprenorphine hydrochloride |
| 10/04/2006 | EP1143931B1 Pulmonary drug delivery |
| 10/04/2006 | EP0964702B1 Polypeptides having a single covalently bound n-terminal water-soluble polymer |
| 10/04/2006 | CN1842530A Methanesulfonic acid salt of pyrazolopyrimidine compound, crystal thereof, and process for producing the same |
| 10/04/2006 | CN1842348A Galactomannans and/or glucomannans for increasing the bioavailability of active substances |
| 10/04/2006 | CN1842347A Active energy radiation hardenable skin plaster composition and skin plaster |
| 10/04/2006 | CN1842345A Oral solid dose vaccine |
| 10/04/2006 | CN1842333A Sustained release tablet for oral use |
| 10/04/2006 | CN1842325A Dosage form |
| 10/04/2006 | CN1842324A Pharmaceutical composition with improved solubility and fluidity |
| 10/04/2006 | CN1842320A Formulations for coated microprojections containing non-volatile counterions |
| 10/04/2006 | CN1842316A Pharmaceutical and cosmetic formulations for treating fingernails |
| 10/04/2006 | CN1840706A Small interfering RNA and single-wall carbon nanotube composite and preparation process and use thereof |
| 10/04/2006 | CN1840201A Polyethylene glycol prodrug of gambogicacid, its preparation method, formulation and use |
| 10/04/2006 | CN1840200A Folacin-starch nanometer granule, its preparation method and application |
| 10/04/2006 | CN1840199A Amphiphilic tri-block copolymer-paclitaxel bonded drug and preparation method thereof |
| 10/04/2006 | CN1840198A Solubilization carrier for drug, its preparation method and application |
| 10/04/2006 | CN1840197A Application of pachyman as disintegrating agent in preparation of medicinal tablet |
| 10/04/2006 | CN1840196A Dispersible preparation adaptable to indissoluble drug |
| 10/04/2006 | CN1840167A Method for preparing anti-diarrhea Chinese medicinal oral gel for infant |
| 10/04/2006 | CN1839908A Medicine composition for treating virus cold and preparing process |
| 10/04/2006 | CN1839877A Pharmaceutical compositions for the oral administration of heparin or derivatives thereof |
| 10/04/2006 | CN1839843A Fluorouracil slow release injection |
| 10/04/2006 | CN1839841A Production method of odor-masking enrofloxacin |
| 10/04/2006 | CN1839839A Preparation method of ziprasidone or its salt inclusion |
| 10/04/2006 | CN1839828A Ramatroban cyclodextrin inclusion |
| 10/04/2006 | CN1839824A Emulsion medicine containing n-NBP for injection and its preparation method |
| 10/04/2006 | CN1839820A Antidepressant composition containing citalopram and cyclodextrin |
| 10/04/2006 | CN1839817A Anticancer slow release injection containing taxone |
| 10/04/2006 | CN1839806A Methods for in vivo delivery of biologics and compositions useful therefor |
| 10/04/2006 | CN1839805A Chitose base self-assembly nano microcapsule preparation method and its drug release regulation method |
| 10/04/2006 | CN1839804A Multilayer phospholipid protein microcapsule for drug slow release wall material and its preparation method |
| 10/04/2006 | CN1839801A Insoluble pharmaceutical slow release preparation |
| 10/04/2006 | CN1839799A Agglutinin-modified drug delivery system from nose to brain |
| 10/04/2006 | CN1839797A In situ quick preparation method of injectable supermolecular structure water gel and its uses |
| 10/04/2006 | CN1277535C Ibuprofen active agent preparation |
| 10/04/2006 | CN1277534C Anti infection agent and its application |
| 10/04/2006 | CN1277531C Polymer material pharmaceutical preparation capsule releasing under control of outer environment pH value |
| 10/03/2006 | US7115798 Methods for regulated expression of triats in plants using multiple site-specific recombination systems |
| 10/03/2006 | US7115727 Comprise oligopeptide for diagnosis, prognosis, prevention and treatment of tumors/cancer |
| 10/03/2006 | US7115725 Polypeptide for use in the generation of vaccine against diphtheria toxin |
| 10/03/2006 | US7115718 Haptens, immunogens, antibodies and conjugates to 2-oxo-3-hydroxy-LSD |
| 10/03/2006 | US7115707 Amino acid sequences capable of facilitating penetration across a biological barrier |
| 10/03/2006 | US7115688 Making the nanoparticles which utilizes a transition-metal ring-opening metathesis polymerization of cyclic olefin (norbornene) derivatives, having a selected property |
| 10/03/2006 | US7115667 Protective film containing glycerides for interface between eyes and contact lenses |
| 10/03/2006 | US7115663 Increased or improved bioavailability of the active agent |
| 10/03/2006 | US7115599 Guanylate cyclase stimulant; cardiovascular disorders; thrombosis; antiischemic agents; sexual disorders; antiinflammatory agents; central nervous system disorders |
| 10/03/2006 | US7115587 Aripiprazole complex formulation and method |
| 10/03/2006 | US7115586 Non-inclusion cyclodextrin complexes |
| 10/03/2006 | US7115583 Microbubble compositions and methods for oligonucleotide delivery |
| 10/03/2006 | US7115581 Autoimmune disease therapy; injections |
| 10/03/2006 | US7115576 Water-soluble antibiotic comprising an amino sugar, in the form of a polysaccharide conjugate |
| 10/03/2006 | US7115573 Prodrug compounds with an isoleucine |
| 10/03/2006 | US7115566 For improved drug delivery |
| 10/03/2006 | US7115565 Chemotherapeutic microemulsion compositions of paclitaxel with improved oral bioavailability |
| 10/03/2006 | US7115562 Peptides and their use to ameliorate cell death |
| 10/03/2006 | US7115297 Shelf-stable, ready to use; to enhance delivery of active medicants/ingredients of pharmaceuticals, nutraceuticals, dietary supplements, therapeutics, diagnostics |
| 10/03/2006 | US7115280 Particle formation methods and their products |
| 10/03/2006 | US7115279 Pharmaceutical compositions of cholesteryl ester transfer protein inhibitors |
| 10/03/2006 | US7115275 System for delivering a composition to the nasal membrane and method of using same |
| 10/03/2006 | US7115261 Combination of an alpha v beta 3 angiogenisis antagonist and an anti-tumor immunotherapeutic agent, which is a fusion protein of a cytokine IL-2 and an Ig heavy chain that immunoreacts with a tumor associated antigen target. |
| 10/03/2006 | US7115256 Methods of treating schizophrenia |
| 10/03/2006 | US7115253 Stabilizing levogyrous acid or proanthocyanidines by contacting with a glycol oxygen-removing compound, a hydroxyethylidenediphosphonic acid, ethylenediamine- or diethylenetriamine- methane phosphonic acid or a sodium salt of the acids as a metallic ion sequestering compound, and a reducing agent |
| 10/03/2006 | US7115252 For restoration and maintenance of gingival and periodontal health; antiplaque/antitar agents; mouthwash |
| 10/03/2006 | US7115250 Heating erectile dysfunction drug to vaporize; cooling to form condensation aerosol; drug delivery |
| 10/03/2006 | US7115248 Conjugates of an annexin, a NxSy or a N4 chelating compound, and a hexose moiety recognized by a mammalian liver receptor that is conjugated to the annexin directly or via the chelating compound; useful for imaging vascular thrombi |
| 10/03/2006 | CA2412671C Tablet shapes to enhance gastric retention of swellable controlled-release oral dosage forms |
| 10/03/2006 | CA2346438C Utilisation of dialkylfumarates for treating host-versus-graft reactions and auto-immune diseases |
| 10/03/2006 | CA2261879C Aerosol formulations |
| 10/03/2006 | CA2252394C Hydrolyzed cellulose granulations for pharmaceuticals |
| 10/03/2006 | CA2251840C Composition, barrier film, and method for preventing contact dermatitis |
| 10/03/2006 | CA2250115C Fast disintegrating oral dosage form |
| 10/03/2006 | CA2225741C Ionophore antibiotic formulations |
| 10/03/2006 | CA2099493C Water-soluble delivery systems for hydrophobic liquids |
| 10/03/2006 | CA2082495C A pharmaceutical preparation containing n-glycofurols and n-ethylene glycols |
| 09/28/2006 | WO2006102395A2 Delivery systems and methods for diagnosing and treating cardiovascular diseases |
| 09/28/2006 | WO2006102345A2 Methods and systems for operating an aerosol generator |
| 09/28/2006 | WO2006102117A1 Nanoparticulate biphosphonate compositions |
| 09/28/2006 | WO2006102108A2 Fucoidan compositions and methods for dietary and nutritional supplements |
| 09/28/2006 | WO2006101839A2 Enhanced bimatoprost ophthalmic solution |
| 09/28/2006 | WO2006101815A2 Pharmaceutical compositions comprising polyoxaester and active agents for use with osmotic delivery systems |
| 09/28/2006 | WO2006101782A2 A cysteine-containing peptide tag for site-specific conjugation of proteins |
| 09/28/2006 | WO2006101409A1 Use of vegetable oil to stabilise essential oils and promote absorption across skin |
| 09/28/2006 | WO2006101173A1 Preparation comprising microparticles of complex composed of nucleic acid molecule and collagen |
| 09/28/2006 | WO2006101106A1 Precious metal nanocolloid solution |
| 09/28/2006 | WO2006100875A1 Pharmaceutical composition |
| 09/28/2006 | WO2006100687A1 Disodium pamidronate aqueous formulation |